SI1105105T1 - Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole - Google Patents

Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole

Info

Publication number: SI1105105T1
Authority: SI; Slovenia
Prior art keywords: ylmethylsulfinyl; benzimidazoles; pyridin; oral administration; administration form
Prior art date: 1998-08-12

Application number

SI9930905T

Other languages

English (en)

Inventor

Rango Dietrich

Hartmut Ney

Original Assignee

Altana Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-12

Filing date

1999-08-07

Publication date

2006-08-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8232445&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1105105(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-08-07 Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag

2006-08-31 Publication of SI1105105T1 publication Critical patent/SI1105105T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

SI9930905T 1998-08-12 1999-08-07 Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole SI1105105T1 (sl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98115141		1998-08-12
PCT/EP1999/005724 WO2000009092A1 (en)	1998-08-12	1999-08-07	Oral administration form for pyridin-2-ylmethylsulfinyl-1h-benzimidazoles

Publications (1)

Publication Number	Publication Date
SI1105105T1 true SI1105105T1 (sl)	2006-08-31

Family

ID=8232445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI9930905T SI1105105T1 (sl)	1998-08-12	1999-08-07	Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole

Country Status (12)

Country	Link
US (3)	US7041313B1 (sl)
EP (1)	EP1105105B1 (sl)
JP (1)	JP4988088B2 (sl)
AT (1)	ATE321538T1 (sl)
AU (2)	AU772726B2 (sl)
CA (2)	CA2340054C (sl)
DE (1)	DE69930648T2 (sl)
DK (1)	DK1105105T3 (sl)
ES (1)	ES2262335T3 (sl)
PT (1)	PT1105105E (sl)
SI (1)	SI1105105T1 (sl)
WO (1)	WO2000009092A1 (sl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US20020019642A1 (en)	1996-07-23	2002-02-14	Keith Milliman	Anastomosis instrument and method for performing same
SE9902386D0 (sv) *	1999-06-22	1999-06-22	Astra Ab	New formulation
EP1326542B1 (en) *	2000-10-18	2008-01-09	Tyco Healthcare Group Lp	Anastomosis instrument
SE0101379D0 (sv)	2001-04-18	2001-04-18	Diabact Ab	Komposition som hämmar utsöndring av magsyra
US7241302B2 (en)	2001-10-18	2007-07-10	Tyco Healthcare Group Lp	Anastomosis instrument and method for performing same
GB0209265D0 (en) *	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
US7195142B2 (en)	2003-05-30	2007-03-27	Tyco Healthcare Group Lp	End-to-end anastomosis instrument and method for performing same
SE0203065D0 (sv)	2002-10-16	2002-10-16	Diabact Ab	Gastric acid secretion inhibiting composition
MY148805A (en)	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
JP2004231520A (ja) *	2003-01-28	2004-08-19	Nichiko Pharmaceutical Co Ltd	保存安定性及び溶出速度に優れた医薬組成物
PE20050150A1 (es)	2003-05-08	2005-03-22	Altana Pharma Ag	Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
CL2004000983A1 (es)	2003-05-08	2005-03-04	Altana Pharma Ag	Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) *	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8461187B2 (en)	2004-06-16	2013-06-11	Takeda Pharmaceuticals U.S.A., Inc.	Multiple PPI dosage form
WO2017125912A1 (en)	2016-01-21	2017-07-27	Dexcel Pharma Technologies Ltd.	Methods for treating helicobacter infection

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE7804231L (sv)	1978-04-14	1979-10-15	Haessle Ab	Magsyrasekretionsmedel
IL75400A (en)	1984-06-16	1988-10-31	Byk Gulden Lomberg Chem Fab	Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja)	1984-08-16	1986-03-13	Takeda Chem Ind Ltd	ピリジン誘導体およびその製造法
AU4640985A (en)	1984-08-31	1986-03-06	Nippon Chemiphar Co. Ltd.	Benzimidazole derivatives
JPS61100526A (ja) *	1984-10-22	1986-05-19	Kyowa Hakko Kogyo Co Ltd	持続性ドパミン経黒剤
GB2189698A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated omeprazole tablets
GB2189699A (en)	1986-04-30	1987-11-04	Haessle Ab	Coated acid-labile medicaments
JPS6339814A (ja) *	1986-08-01	1988-02-20	Teisan Seiyaku Kk	トラニラストの経口用持続性製剤
FI90544C (fi)	1986-11-13	1994-02-25	Eisai Co Ltd	Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JP2602518B2 (ja)	1988-01-27	1997-04-23	エーザイ株式会社	被覆された胃酸分泌抑制剤含有組成物
DE3822095A1 (de) *	1988-06-30	1990-01-04	Klinge Co Chem Pharm Fab	Neue arzneimittelformulierung sowie verfahren zu deren herstellung
EP0434999B1 (en)	1989-11-29	1994-08-17	Toa Eiyo Ltd.	Cycloheptenopyridine derivatives, process for preparation thereof and antiulcer agents containing the same
US5229131A (en) *	1990-02-05	1993-07-20	University Of Michigan	Pulsatile drug delivery system
KR930006431B1 (ko) *	1990-10-11	1993-07-16	재단법인 한국화학연구소	약물의 미세캡슐화 방법
YU48263B (sh) *	1991-06-17	1997-09-30	Byk Gulden Lomberg Chemische Fabrik Gmbh.	Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
IT1251153B (it) *	1991-08-06	1995-05-04	Vectorpharma Int	Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
US5260068A (en) *	1992-05-04	1993-11-09	Anda Sr Pharmaceuticals Inc.	Multiparticulate pulsatile drug delivery system
FR2692146B1 (fr) *	1992-06-16	1995-06-02	Ethypharm Sa	Compositions stables de microgranules d'omeprazole gastro-protégés et leur procédé d'obtention.
WO1994002140A1 (en)	1992-07-17	1994-02-03	Astra Aktiebolag	Pharmaceutical composition containing antiulcer agent
US5260069A (en) *	1992-11-27	1993-11-09	Anda Sr Pharmaceuticals Inc.	Pulsatile particles drug delivery system
JPH0710758A (ja) *	1993-06-22	1995-01-13	Nippon Iyakuhin Kogyo Kk	持続性セファクロル製剤
SE9402431D0 (sv)	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
ES2094694B1 (es)	1995-02-01	1997-12-16	Esteve Quimica Sa	Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion.
SE9500478D0 (sv)	1995-02-09	1995-02-09	Astra Ab	New pharmaceutical formulation and process
US5567441A (en) *	1995-03-24	1996-10-22	Andrx Pharmaceuticals Inc.	Diltiazem controlled release formulation
US5945124A (en) *	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
DE69628444T2 (de)	1995-09-21	2004-05-06	Pharma Pass Ii Llc, Irvine	Säurelabile omeprazol enthaltende pharmazeutische zusammensetzung und verfahren zu dessen herstellung
US5840332A (en) *	1996-01-18	1998-11-24	Perio Products Ltd.	Gastrointestinal drug delivery system
US6245351B1 (en) *	1996-03-07	2001-06-12	Takeda Chemical Industries, Ltd.	Controlled-release composition
SE9602442D0 (sv)	1996-06-20	1996-06-20	Astra Ab	Administration of pharmaceuticals
US6623759B2 (en) *	1996-06-28	2003-09-23	Astrazeneca Ab	Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
DE19626045C2 (de)	1996-06-28	1998-12-03	Klinge Co Chem Pharm Fab	Stabile Arzneiform zur oralen Verabreichung, welche Omeprazol als aktiven Wirkstoff enthält, sowie Verfahren zur Herstellung derselben
SE9704870D0 (sv)	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulation I
US6749867B2 (en) *	2000-11-29	2004-06-15	Joseph R. Robinson	Delivery system for omeprazole and its salts

1999
- 1999-08-07 DE DE69930648T patent/DE69930648T2/de not_active Expired - Lifetime
- 1999-08-07 DK DK99941537T patent/DK1105105T3/da active
- 1999-08-07 ES ES99941537T patent/ES2262335T3/es not_active Expired - Lifetime
- 1999-08-07 US US09/762,302 patent/US7041313B1/en not_active Expired - Fee Related
- 1999-08-07 AT AT99941537T patent/ATE321538T1/de active
- 1999-08-07 PT PT99941537T patent/PT1105105E/pt unknown
- 1999-08-07 WO PCT/EP1999/005724 patent/WO2000009092A1/en active IP Right Grant
- 1999-08-07 JP JP2000564595A patent/JP4988088B2/ja not_active Expired - Fee Related
- 1999-08-07 CA CA002340054A patent/CA2340054C/en not_active Expired - Fee Related
- 1999-08-07 EP EP99941537A patent/EP1105105B1/en not_active Revoked
- 1999-08-07 CA CA002507743A patent/CA2507743C/en not_active Expired - Fee Related
- 1999-08-07 AU AU55114/99A patent/AU772726B2/en not_active Ceased
- 1999-08-07 SI SI9930905T patent/SI1105105T1/sl unknown
2004
- 2004-05-21 AU AU2004202162A patent/AU2004202162B2/en not_active Ceased
2006
- 2006-03-17 US US11/377,404 patent/US7402321B2/en not_active Expired - Fee Related
2008
- 2008-05-21 US US12/153,585 patent/US8465767B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP4988088B2 (ja)	2012-08-01
JP2002522472A (ja)	2002-07-23
US7402321B2 (en)	2008-07-22
EP1105105B1 (en)	2006-03-29
DE69930648D1 (de)	2006-05-18
AU2004202162B2 (en)	2007-03-08
US8465767B2 (en)	2013-06-18
PT1105105E (pt)	2006-07-31
CA2507743C (en)	2008-03-18
US7041313B1 (en)	2006-05-09
CA2507743A1 (en)	2000-02-24
ES2262335T3 (es)	2006-11-16
AU2004202162A1 (en)	2004-06-17
US20080226712A1 (en)	2008-09-18
AU772726B2 (en)	2004-05-06
DE69930648T2 (de)	2006-12-21
DK1105105T3 (da)	2006-07-17
AU5511499A (en)	2000-03-06
US20060263426A1 (en)	2006-11-23
EP1105105A1 (en)	2001-06-13
WO2000009092A1 (en)	2000-02-24
ATE321538T1 (de)	2006-04-15
CA2340054A1 (en)	2000-02-24
CA2340054C (en)	2005-10-18

Publication	Publication Date	Title
SI1105105T1 (sl)	2006-08-31	Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
AP9901534A0 (en)	1999-06-30	Pharmaceutical formulations.
IL99759A (en)	1997-06-10	Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
PL341054A1 (en)	2001-03-26	Novel suppositiories containing an active compound being unstable in acid environments
EP1193270A3 (en)	2002-04-17	Pyrrolobenzodiazepines
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
MXPA02003977A (es)	2003-09-25	Inhibidores de adhesion de celula mediada por al°2.
EP0840606A4 (sl)	1998-05-13
GEP20032938B (en)	2003-04-25	Acaricide
RS49708B (sr)	2007-12-31	Oralne kompozicije levosimendana
DE69631609D1 (en)	2004-03-25	Tricyclische erythromycinderivate
SI1121127T1 (sl)	2005-06-30	Buprenorfin vsebujoča zdravila za oralno aplikacijo
ATE252377T1 (de)	2003-11-15	Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
GB9718903D0 (en)	1997-11-12	Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
TW200716550A (en)	2007-05-01	Pharmaceutical composition comprising ritonavir
JO1704B1 (en)	1992-12-15	New potent compounds
GB9907571D0 (en)	1999-05-26	Compounds
JO2065B1 (en)	2000-05-21	Tri-azin compounds
EP0816366A4 (en)	1998-07-08	IMIDAZOTHIAZOLE COMPOUNDS
EP1026162A4 (en)	2001-01-17	ANTI-RHUMATISMAL AGENT
MX9709453A (es)	1998-02-28	Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
CS240991A3 (en)	1992-03-18	Solid forms for oral administration, said forms containing iphosphamide as active component
NZ515685A (en)	2002-12-20	Use of riluzole for the treatment of multiple sclerosis
IL100955A (en)	1997-03-18	Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
MXPA02011410A (es)	2003-06-06	Uso de compuestos 1-amino-5-fenilpentan-3-ol y/o 1-amino-6-fenilhexan-3-ol substituidos como medicamentos.